AzTrials
AzTrials

Bilateral Sensorineural Hearing LossNCT05962359

Neural Prediction to Enhance Language

A study testing Parent-Implemented Communication Treatment in people with Bilateral Sensorineural Hearing Loss and Speech and Language Development Delay Due to Hearing Loss, run by Ann & Robert H Lurie Children's Hospital of Chicago at 1 site in United States.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The language outcome of children receiving cochlear implantation to address bilateral sensorineural hearing loss is more variable than that of typical hearing children. The research is focused upon development of neural predictive models based upon brain imaging to forecast language after cochlear implantation on the… Read more about this study

Who is it for?
Ages 0 months to 5 years
What is being tested?
Parent-Implemented Communication Treatment
Could I receive a placebo?
No, everyone receives an active treatment
How many people
700 participants
Where
1 siteUnited States
Study dates
23 Jan 2023to 23 Jan 2028
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 0 months to 5 years
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • Children with sensorineural hearing loss who meet clinical criteria for cochlear implantation in both ears who meet the following age criteria at time cochlear implant evaluation begins:
  • Age 5 years and under.
  • English or Spanish as the dominant language.
  • English or Spanish dominant language in the home.
  • Children with bilateral sensorineural hearing loss who meet clinical criterial for cochlear implantation
  • English dominant spoken language by family
Show all 9Show fewer
  • Age at implantation of 36 months and younger when treatment begins
  • Parent or caregiver that is willing to participate who understands spoken English
  • Child is exposed to spoken language by at least one parent (total communication or auditory/oral) in the home

Who cannot join

  • Severe motor and /or cognitive disability that would preclude evaluation of progress
  • Limited electrode insertion likely to significantly impact development of speech perception
  • Hearing loss due to bacterial meningitis
  • Neither English or Spanish as the dominant family language in the home
  • Severe motor and /or cognitive disability that would preclude evaluation of progress
  • Limited electrode insertion likely to significantly impact development of speech perception
Show all 12Show fewer
  • Hearing loss due to bacterial meningitis
  • Dominant language other than English
  • Diagnoses or medical conditions expected to impact language development independent of hearing loss
  • Cochlear nerve deficiency in implanted ears or severe cochlear malformation
  • Children already having spoken language who score better than 25th percentile on the Words and Sentences portion of the CDI language evaluation.
  • Child with more than two months CI experience prior to start of treatment

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Nancy M Young, MD contact

312-227-6812

nyoung@luriechildrens.org

Emily (Shimeng) Xu, PhD contact

sxu@luriechildrens.org

United States1 site, 1 recruiting
  • Ann & Robert H. Lurie Children's Hospital of Chicago

    Chicago, Illinois, 60611

    Nancy Young, MD, nyoung@luriechildrens.org

    Recruiting

Other trials in United States

About this study

Official title: Neural Prediction to Enhance Language Outcomes in Children With Cochlear Implant

The language outcome of children receiving cochlear implantation to address bilateral sensorineural hearing loss is more variable than that of typical hearing children. The research is focused upon development of neural predictive models based upon brain imaging to forecast language after cochlear implantation on the individual child level. The long-term goal is improving children's language by using predictive models to enable a custom "predict to prescribe" approach to intervene with more effective behavioral therapy for children at risk to develop poorer language. The investigators previously developed models for short term language outcome of English-learning implanted children. The aims of this study are to 1. Develop models able to predict long term outcome for English- learning and Spanish-learning children; and 2. To evaluate whether English-learning children predicted to achieve lower language based on the investigators' previously constructed models can demonstrate significant gains from Parent Implemented Communication Treatment (PICT). PICT is an intensive parent education program about strategies to improve children's communication.

Read the detailed description

Arm1: Non-treatment Model Building. Up to 700 children will be recruited from 5 cochlear implant programs in the United States. Children will be enrolled and followed for up to four years after implantation. Study information will be obtained from each child's medical record before and after implantation including cause of hearing loss, general health, language and communication history, family history, cochlear implant device and surgery. Audiological information before and after implantation will be collected from routine visits that are part of cochlear implant candidacy evaluation and audiology evaluations after implantation. This includes audiology evaluations after activation of the cochlear implant that take place at around 6, 12, 18, 24, 36 and/or 48 months. Pre-surgical MRI done at each participating site as part of routine pre-operative evaluation will also be collected for analysis. If enrolled into the study at Lurie Children's Hospital of Chicago before the pre-surgical MRI is done, the parent or guardian will have the option to have their child undergo additional research scans during the pre-surgical MRI.

Parents will be asked to complete baseline and follow-up surveys. The surveys will ask about family demographic and health information, language exposure in the home, therapy and school services, and language and communication ability of the child. Parental surveys will be readministered at about 12-month intervals after the child's device is turned on. In addition, surveys about the child's cognition will be sent to parents after their child has used their implant for one and two years. Surveys will be offered online by a secure link provided during clinical visits, emailed after the visit or sent by MyChart to the parent/guardian for completion at home.

An in-person research-only speech and language evaluation will be done at about one-year intervals after initial implantation during each year the child is enrolled in the study. The evaluation will take less than two hours.

Arm 2: Experimental: Communication Treatment is terminated. Study#372634 (the human subjects study record) to be removed/terminated in ASSIST.

Being tested
Parent-Implemented Communication Treatment
Keywords
Hearing Loss, Children, Parent-mediated intervention, Language prediction
Medical subject headings
Speech, Communication, Hearing Loss

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Parent-Implemented Communication TreatmentBehavioural

    The intervention will be taught by a qualified professional online and/or in-person for about 6 months. Parents will learn strategies to enhance their children's social communication and will receive coaching and feedback.

Study groups in NCT05962359
Study groupRoleWhat they receive
Non-treatment Model BuildingNo interventionNot described
Communication TreatmentExperimentalTerminated
Receives: Behavioral: Parent-Implemented Communication Treatment

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Preschool Language Scales, Fifth Edition (PLS-5)

    A standardized measure of auditory comprehension and expressive communication in children. Standard scores are obtained which are then translated to percentiles, and age equivalents. Higher standard scores indicate better performance.

    Measured: At 12 months after cochlear implant activation

  2. Preschool Language Scales, Fifth Edition (PLS-5)

    A standardized measure of auditory comprehension and expressive communication in children. Standard scores are obtained which are then translated to percentiles, and age equivalents. Higher standard scores indicate better performance.

    Measured: At 24 months after cochlear implant activation

  3. Preschool Language Scales, Fifth Edition (PLS-5)

    A standardized measure of auditory comprehension and expressive communication in children. Standard scores are obtained which are then translated to percentiles, and age equivalents. Higher standard scores indicate better performance.

    Measured: At 36 months after cochlear implant activation

  4. Preschool Language Scales, Fifth Edition (PLS-5)

    A standardized measure of auditory comprehension and expressive communication in children. Standard scores are obtained which are then translated to percentiles, and age equivalents. Higher standard scores indicate better performance.

    Measured: At 48 months after cochlear implant activation

  5. Expressive One-Word Picture Vocabulary Test, Fourth Edition (EOWPVT-4)

    An individually administered, norm-referenced assessment of how well a person can name objects, actions, or concepts presented in full-color pictures. Raw scores are obtained which are then translated to standard scores, percentiles, and age equivalents. Both higher standard scores and raw scores indicate better performance.

    Measured: At 12 months after cochlear implant activation

  6. Expressive One-Word Picture Vocabulary Test, Fourth Edition (EOWPVT-4)

    An individually administered, norm-referenced assessment of how well a person can name objects, actions, or concepts presented in full-color pictures. Raw scores are obtained which are then translated to standard scores, percentiles, and age equivalents. Both higher standard scores and raw scores indicate better performance.

    Measured: At 24 months after cochlear implant activation

  7. Expressive One-Word Picture Vocabulary Test, Fourth Edition (EOWPVT-4)

    An individually administered, norm-referenced assessment of how well a person can name objects, actions, or concepts presented in full-color pictures. Raw scores are obtained which are then translated to standard scores, percentiles, and age equivalents. Both higher standard scores and raw scores indicate better performance.

    Measured: At 36 months after cochlear implant activation

  8. Expressive One-Word Picture Vocabulary Test, Fourth Edition (EOWPVT-4)

    An individually administered, norm-referenced assessment of how well a person can name objects, actions, or concepts presented in full-color pictures. Raw scores are obtained which are then translated to standard scores, percentiles, and age equivalents. Both higher standard scores and raw scores indicate better performance.

    Measured: At 48 months after cochlear implant activation

  9. MacArthur-Bates Communicative Development Inventory (CDI)

    A set of online parent report intruments that evaluate children's early speech and langauge development. Standard scores are based on percentiles for age and sex and range from 1 to 99th percentile. Higher standard scores indicate better performance.

    Measured: At 12 months after cochlear implant activation

  10. MacArthur-Bates Communicative Development Inventory (CDI)

    A set of online parent report intruments that evaluate children's early speech and langauge development. Standard scores are based on percentiles for age and sex and range from 1 to 99th percentile. Higher standard scores indicate better performance.

    Measured: At 24 months after cochlear implant activation

  11. MacArthur-Bates Communicative Development Inventory (CDI)

    A set of online parent report intruments that evaluate children's early speech and langauge development. Standard scores are based on percentiles for age and sex and range from 1 to 99th percentile. Higher standard scores indicate better performance.

    Measured: At 36 months after cochlear implant activation

  12. MacArthur-Bates Communicative Development Inventory (CDI)

    A set of online parent report intruments that evaluate children's early speech and langauge development. Standard scores are based on percentiles for age and sex and range from 1 to 99th percentile. Higher standard scores indicate better performance.

    Measured: At 48 months after cochlear implant activation

Secondary outcomes (10)
  1. Behavior Rating Inventory of Executive Function (BRIEF)

    A parent-reported executive function questionnaire that utilizes T-scores to reflect individual's level of executive functioning. Higher T-scores indicate better performance.

    Measured: At 12 months after cochlear implant activation

  2. Behavior Rating Inventory of Executive Function (BRIEF)

    A parent-reported executive function questionnaire that utilizes T-scores to reflect individual's level of executive functioning. Higher T-scores indicate better performance.

    Measured: At 24 months after cochlear implant activation

  3. Behavior Rating Inventory of Executive Function - Preschool Version (BRIEF-P)

    A parent-reported executive function questionnaire designed for preschool-aged children that utilizes T-scores to reflect children's level of executive functioning. Higher T-scores indicate better performance.

    Measured: At 12 months after cochlear implant activation

  4. Behavior Rating Inventory of Executive Function - Preschool Version (BRIEF-P)

    A parent-reported executive function questionnaire designed for preschool-aged children that utilizes T-scores to reflect children's level of executive functioning. Higher T-scores indicate better performance.

    Measured: At 24 months after cochlear implant activation

  5. Pediatric Minimum Speech Test Battery (PMSTB)

    A set of measures designed to evaluate speech discrimination for infants and word/ sentence recognition for children using hearing technology before entering school. Scores range from 0 to 700. Higher scores indicate better performance.

    Measured: At 6 months after cochlear implant activation

  6. Pediatric Minimum Speech Test Battery (PMSTB)

    A set of measures designed to evaluate speech discrimination for infants and word/ sentence recognition for children using hearing technology before entering school. Scores range from 0 to 700. Higher scores indicate better performance.

    Measured: At 12 months after cochlear implant activation

  7. Pediatric Minimum Speech Test Battery (PMSTB)

    A set of measures designed to evaluate speech discrimination for infants and word/ sentence recognition for children using hearing technology before entering school. Scores range from 0 to 700. Higher scores indicate better performance.

    Measured: At 18 months after cochlear implant activation

  8. Pediatric Minimum Speech Test Battery (PMSTB)

    A set of measures designed to evaluate speech discrimination for infants and word/ sentence recognition for children using hearing technology before entering school. Scores range from 0 to 700. Higher scores indicate better performance.

    Measured: At 24 months after cochlear implant activation

  9. Pediatric Minimum Speech Test Battery (PMSTB)

    A set of measures designed to evaluate speech discrimination for infants and word/ sentence recognition for children using hearing technology before entering school. Scores range from 0 to 700. Higher scores indicate better performance.

    Measured: At 36 months after cochlear implant activation

  10. Pediatric Minimum Speech Test Battery (PMSTB)

    A set of measures designed to evaluate speech discrimination for infants and word/ sentence recognition for children using hearing technology before entering school. Scores range from 0 to 700. Higher scores indicate better performance.

    Measured: At 48 months after cochlear implant activation

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted27 Jul 2023
  2. Study start23 Jan 2023
  3. Primary completion23 Jul 2027 (estimated)
  4. Study completion23 Jan 2028 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Non-randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
700 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05962359
Sponsor's protocol ID
R01DC019387
Status last verified
Jun 2026
First submitted
6 Jul 2023
Last updated
2 Jul 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Parent-Implemented Communication Treatment in people with Bilateral Sensorineural Hearing Loss and Speech and Language Development Delay Due to Hearing Loss, run by Ann & Robert H Lurie Children's Hospital of Chicago at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 9 inclusion and 12 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 2 Jul 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Nancy M Young, MD (312-227-6812, nyoung@luriechildrens.org), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Preschool Language Scales, Fifth Edition (PLS-5) (time frame: At 12 months after cochlear implant activation). The study lists 12 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 Jul 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in